News

Floretina, a leading publication platform in retina research, hosted the 12th International Congress on OCT and OCT Angiography (ICOOR) from December 5-8, 2024 in Florence, Italy. The event featured live surgery sessions, video libraries, and an interactive app, making it a hub of innovation and learning.

Rupalatha Maddala, PhD was the lead author of the cover focus, of the Journal of Cell Science Insight's December Issue. Duke Co-authors include Pallavi Gorijavolu, Levi Lankford, Nikolai Skiba, PhD. Pratap Challa, MD, and Ponugoti Rao, PhD.

In a recent article from AARP discussing health conditions that worsen in the winter, Corina Busuioc, OD shares how cold weather can exacerbate dry eye syndrome and what can be done to prevent and manage discomfort from this condition.

Duke Eye Center is proud to announce the recipients of the VitreoRetinal Surgery Foundation (VRSF) Research Award.

Amit Narawane, a Duke graduate student under the mentorship of Dr. Cynthia Toth, has been awarded a $10,000 grant by the VitreoRetinal Surgery Foundation Research Fellowship to support his project on "Pupil Tracking and Motion Compensation for Handheld Pediatric Retinal Imaging." Additionally, Amit will receive up to $1,000 for travel expenses to present his research at a national meeting.

In this season of Thanksgiving, we express our gratitude not only for the opportunity to care for our patients but also for the inspiration they provide for our research.

A new study reveals a potential blind spot in the methods doctors use to predict glaucoma risk, particularly for Black patients. 

The FDA has approved a new light delivery system termed photobiomodulation for treating intermediate dry age-related macular degeneration (AMD), a major cause of vision loss in people over 55. This is the first FDA-approved treatment for vision loss in dry AMD patients. The therapy has shown to improve vision by more than 5 letters on an eye chart over 24 months. This non-invasive treatment offers a new option for patients to improve their vision earlier in the disease process.

Professor of Ophthalmology, Paloma Liton, PhD, FARVO, served as editor, along with Tatjana Jakobs, MD, for the newly released Second Edition of “Glaucoma: Methods and Protocols”. This updated volume explores the latest methodologies for studying glaucoma neurodegeneration, with a special focus on ocular hypertension and its role in the disease’s pathogenesis.

The Benign Essential Blepharospasm Research Foundation held its annual symposium November 1-2, 2024 at Duke Eye Center. The program was led by Professor of Ophthalmology, Julie Woodward, MD. Attendees learned about blepharospasm, Meige, and other related disorders and had the opportunity to hear from experts in the field, connect with other patients and caregivers, and participate in Q&A sessions.